Drug Approval | March 19, 2025
Briefs: Zydus, Alkem Laboratories, Alkem Medtech and Relonchem
Alkem Medtech to acquire 100% stake of Bombay Ortho
Alkem Medtech to acquire 100% stake of Bombay Ortho
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
This e-commerce platform is launched as a hyperlocal model
There are 38.4 million people with diabetes in the United States
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Subscribe To Our Newsletter & Stay Updated
